论文信息 - Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. - 字舞流文

Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.

M. Prados | J. Uhm | K. Hess | J. Bruner | A. Kyritsis | V. Levin | M. J. Gleason | P. Flynn | K. Jaeckle | A. Choucair | S. Chang | Yung WKA | Janet M. Bruner | Michael D. Prados | Kenneth R. Hess | Victor A. Levin | Susan M. Chang | Patrick J. Flynn | Ali Choucair | W. A. Yung | Joon H. Uhm